Printer Friendly
The Free Library
14,505,384 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Tokyo Institute of Technology Identifies Molecular Switch in Gene Expression.


Tokyo, Japan, Jan 20, 2006 - (JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) 
) - The Tokyo Institute of Technology Tokyo Institute of Technology (東京工業大学   announced on January 20 that Professor Hiroshi Handa's research group of its Graduate School of Bioscience and Biotechnology has identified a molecular switch in gene expression.

The research group has confirmed that P-TEFb, a kind of phosphorylated enzyme, can switch the activity of DSIF DSIF Dirty South Improv Festival
DSIF Deep Space Instrumentation Facility
DSIF Defensive Systems Integration Facility
DSIF Distinguished Space Industry Fellows Program
, a protein that regulates the transcription elongation of genes. Specifically, P-TEFb phosphorylates DSIF so that DSIF can switch on and off the process of gene expression.

Details of the research are available in the January 20 issue of Molecular Cell, a US science magazine, under the title of "P-TEFb-mediated phosphorylation phosphorylation, chemical process in which a phosphate group is added to an organic molecule. In living cells phosphorylation is associated with respiration, which takes place in the cell's mitochondria, and photosynthesis, which takes place in the chloroplasts.  of hSpt5 C-terminal repeats is critical for processive transcription elongation".

Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2006 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Jan 21, 2006
Words:125
Previous Article:Takeda Starts Phase 2 Clinical Studies of ATL-962, an Obesity and Related Disease Treatment, in Japan.
Next Article:Riken Vitamin to Bring to Market No-Oil/Cholesterol Mayonnaise in February.



Related Articles
CH3ips off the old genetic block. (discovery of differences between paternal and maternal genes)
Use molecular tools to determine ability of probiotics to hinder pathogens.
Use of genomics in toxicology and epidemiology: findings and recommendations of a workshop. (Meeting Report).
Overview of an interlaboratory collaboration on evaluating the effects of model hepatotoxicants on hepatic gene expression.(Genomics and Risk...
Quantitative PCR deconstruction of discrepancies between results reported by different hybridization platforms.(Genomics and Risk Assessment:...
Toxicogenomics through the Eyes of Informatics: conference overview and recommendations.(Meeting Report)
GENE EXPRESS TECHNOLOGY RECEIVES INTERNATIONAL PATENTS.
BAC to the future.(Systems Biology)
MediBIC, Kazusa DNA Research Institute to Collaborate in New Drug Development.
Recent applications of DNA microarray technology to toxicology and ecotoxicology.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles